| Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More | Frank Vinluan | 02/28/20 | National |
| Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding | Melissa Fassbender | 12/04/19 | Boston |
| Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels | Frank Vinluan | 10/07/19 | National |
| Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave | Ben Fidler | 07/15/19 | Boston |
| What’s Hot in Boston Biotech 2019: The Photos | Jeff Bauter Engel | 06/04/19 | Boston |
| The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski | Ben Fidler | 03/11/19 | National |
| SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot | David Holley | 08/08/18 | Boston |
| The 2018 Xconomy Awards Finalists Are… | Corie Lok | 06/28/18 | Boston |
| Save $100 Today on “What’s Hot in Boston Biotech” on May 16 | Ashley Gentile | 05/02/18 | Boston |
| Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More | Alex Lash | 04/20/18 | National |
| Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More | Frank Vinluan | 03/16/18 | National |
| Quentis Nets $48M For Cancer Drugs, Building Buzz For NY Bio Startups | Ben Fidler | 02/27/18 | New York |
| The Winners of the 2017 Xconomy Awards Are… | Corie Lok | 09/26/17 | Boston |
| In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions | Alex Lash | 05/31/17 | National |
| On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy | Ben Fidler | 05/30/17 | National |
| FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type | Ben Fidler | 05/23/17 | National |
| Last Chance to Snag a Ticket for What’s Hot in Boston Biotech | Ashley Gentile | 05/10/17 | Boston |
| Grab Your Ticket for What’s Hot in Boston Biotech on May 11th | Ashley Gentile | 05/03/17 | Boston |
| Cellular Dynamics Adds to Stem Cell Work With Harvard Institute | Jeff Buchanan | 04/25/17 | Wisconsin |
| Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today | Ashley Gentile | 04/06/17 | Boston |
| Veering Off Topic With General Catalyst’s Larry Bohn | Jeff Bauter Engel | 03/10/17 | Boston |
| Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy | Ben Fidler | 12/02/16 | Boston |
| Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out | Ben Fidler | 08/08/16 | Boston |
| Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials | Ben Fidler | 06/29/16 | Boston |
| Syros Files For IPO to Push “Gene Control” Drugs Through First Trials | Ben Fidler | 06/06/16 | Boston |
| Amid Leadership Changes, NY Biotech Braces For its “Pivotal Moment” | Ben Fidler | 05/12/16 | New York |
| Making the Price Right: Ideas To Change Drug Costs Gain Momentum | Alex Lash | 04/05/16 | National |
| Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall | Ben Fidler | 03/07/16 | Boston |
| East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More | Ben Fidler | 03/03/16 | Boston |
| East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More | Ben Fidler | 01/08/16 | Boston |
